title: [Current development of new drugs in malignant lymphoma].
authors.affiliation: Department of Hematology & Oncology, Nagoya Daini Red Cross Hospital.
authors.forename: Michinori
authors.initials: M
authors.lastname: Ogura
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D000079963:Brentuximab Vedotin; D004167:Diphtheria Toxin / Q000627:therapeutic use; D055808:Drug Discovery / Q000639:trends; D000068338:Everolimus; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D018796:Immunoconjugates / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D000080045:Inotuzumab Ozogamicin; D007376:Interleukin-2 / Q000627:therapeutic use; D000077269:Lenalidomide; D008223:Lymphoma / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011684:Purine Nucleosides / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077337:Vorinostat
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001897:Boronic Acids; D004167:Diphtheria Toxin; D006877:Hydroxamic Acids; D018796:Immunoconjugates; D007211:Indoles; D007376:Interleukin-2; D009588:Nitrogen Mustard Compounds; D011684:Purine Nucleosides; D011719:Pyrazines; D011744:Pyrimidinones; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox; C113101:forodesine; D013792:Thalidomide; D000077337:Vorinostat; D000069286:Bortezomib; D000079963:Brentuximab Vedotin; D000069461:Bendamustine Hydrochloride; D000068338:Everolimus; D000077269:Lenalidomide; C527517:ofatumumab; D000080045:Inotuzumab Ozogamicin; C504878:enzastaurin; D020123:Sirolimus; C549035:mogamulizumab